- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Breast cancer
- Meeting Date: March 2025
- Public Summary Document (PSD) March 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2025 PBAC Meeting - (Word)
Sacituzumab Govitecan – March 2025
Sacituzumab Govitecan; Powder for injection 180 mg; Trodelvy®
Last updated
12 March 2025